🇺🇸 Tumor necrosis factor alpha in United States

49 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 49

Most-reported reactions

1. Acute Graft Versus Host Disease — 6 reports (12.24%)
2. Acute Graft Versus Host Disease In Intestine — 6 reports (12.24%)
3. Erythema — 6 reports (12.24%)
4. Oedema — 6 reports (12.24%)
5. Toxicity To Various Agents — 6 reports (12.24%)
6. Graft Versus Host Disease — 5 reports (10.2%)
7. Multi-Organ Failure — 5 reports (10.2%)
8. Acute Graft Versus Host Disease In Liver — 3 reports (6.12%)
9. Acute Myeloid Leukaemia — 3 reports (6.12%)
10. Blister — 3 reports (6.12%)

Source database →

Frequently asked questions

Is Tumor necrosis factor alpha approved in United States?

Tumor necrosis factor alpha does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Tumor necrosis factor alpha in United States?

OncoCareClinic 308 Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.